Similar Articles
1141 Management of recurrent hepatocellular carcinoma after liver transplant
1142 Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization
1143 Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy
1144 Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence
1145 Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment
1146 Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma
1147 Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma
1148 Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients
1149 Three-dimensional morphometric analysis for hepatectomy of centrally located hepatocellular carcinoma: A pilot study
1150 Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: Propensity score analysis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA